Home  »  Companies   »  PAVmed Inc. (PAVM) Stock Observes -45.45% 200-Day ...

PAVmed Inc. (PAVM) Stock Observes -45.45% 200-Day Moving Average

The stock of PAVmed Inc. (PAVM) has gone down by -20.82% for the week, with a -16.51% drop in the past month and a -6.59% drop in the past quarter. The volatility ratio for the week is 12.65%, and the volatility levels for the past 30 days are 11.76% for PAVM. The simple moving average for the past 20 days is -15.29% for PAVM’s stock, with a -45.45% simple moving average for the past 200 days.

Is It Worth Investing in PAVmed Inc. (NASDAQ: PAVM) Right Now?

compared to its average ratio and a 36-month beta value of 0.87. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


The average price point forecasted by analysts for PAVmed Inc. (PAVM) is $3.04, which is $2.63 above the current market price. The public float for PAVM is 83.40M, and currently, short sellers hold a 6.17% ratio of that float. The average trading volume of PAVM on May 24, 2023 was 425.06K shares.

PAVM) stock’s latest price update

The stock of PAVmed Inc. (NASDAQ: PAVM) has decreased by -4.42 when compared to last closing price of 0.43.Despite this, the company has seen a loss of -20.82% in its stock price over the last five trading days.

PAVM Trading at -7.19% from the 50-Day Moving Average

After a stumble in the market that brought PAVM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.44% of loss for the given period.

Volatility was left at 11.76%, however, over the last 30 days, the volatility rate increased by 12.65%, as shares sank -14.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -1.01% lower at present.

During the last 5 trading sessions, PAVM fell by -20.82%, which changed the moving average for the period of 200-days by -79.24% in comparison to the 20-day moving average, which settled at $0.4817. In addition, PAVmed Inc. saw -14.37% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at PAVM starting from Glennon Michael J, who purchase 100,000 shares at the price of $0.62 back on Dec 07. After this action, Glennon Michael J now owns 250,000 shares of PAVmed Inc., valued at $62,320 using the latest closing price.

Glennon Michael J, the Director of PAVmed Inc., purchase 88,000 shares at $0.64 during a trade that took place back on Dec 06, which means that Glennon Michael J is holding 150,000 shares at $56,082 based on the most recent closing price.

Stock Fundamentals for PAVM

Current profitability levels for the company are sitting at:

  • -24118.57 for the present operating margin
  • -1510.34 for the gross margin

The net margin for PAVmed Inc. stands at -23602.92. The total capital return value is set at -143.20, while invested capital returns managed to touch -330.60.

When we switch over and look at the enterprise to sales, we see a ratio of 66.00, with the company’s debt to enterprise value settled at 0.58. The receivables turnover for the company is 3.47 and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.07.


To put it simply, PAVmed Inc. (PAVM) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.